Lamoureux P, Steel V L, Regal C, Adgate L, Buxbaum R E, Heidemann S R
Department of Physiology, Michigan State University, East Lansing 48824-1101.
J Cell Biol. 1990 Jan;110(1):71-9. doi: 10.1083/jcb.110.1.71.
Several groups have shown that PC12 will extend microtubule-containing neurites on extracellular matrix (ECM) with no lag period in the absence of nerve growth factor. This is in contrast to nerve growth factor (NGF)-induced neurite outgrowth that occurs with a lag period of several days. During this lag period, increased synthesis or activation of assembly-promoting microtubule-associated proteins (MAPs) occurs and is apparently required for neurite extension. We investigated the growth and microtubule (MT) content of PC12 neurites grown on ECM in the presence or absence of inhibitors of neurite outgrowth. On ECM, neurites of cells with or without prior exposure to NGF contain a normal density of MTs, but frequently contain unusual loops of MTs in their termini that may indicate increased MT assembly. On ECM, neurites extend from PC12 cells in the presence of 10 microM LiCl at significantly higher frequency than on polylysine. On other substrates, LiCl inhibits neurite outgrowth, apparently by inhibiting phosphorylation of particular MAPs (Burstein, D. E., P. J. Seeley, and L. A. Greene. 1985. J. Cell Biol. 101:862-870). Although 35-45% of 60 Li(+)-neurites examined were found to contain a normal array of MTs, 25-30% were found to have a MT density approximately 15% of normal. The remaining 30% of these neurites were found to be nearly devoid of MTs, containing only occasional, ambiguous, short tubular elements. We also found that neurites would extend on ECM in the presence of the microtubule depolymerizing drug, nocodazole. At 0.1 micrograms/ml nocodazole, cells on ECM produce neurites that contain a normal density of MTs. This is in contrast to the lack of neurite outgrowth and retraction of extant neurites that this dose produces in cells grown on polylysine. At 0.2 microgram/ml nocodazole, neurites again grew out in substantial number and four of five neurites examined ultrastructurally were found to be completely devoid of microtubules. We interpret these results by postulating that growth on ECM relieves the need for MTs to serve as compressive supports for neurite tension (Dennerll, T. J., H. C. Joshi, U. L. Steel, R. E. Buxbaum, and S. R. Heidemann. 1988. J. Cell Biol. 107:665). Because compression destabilizes MTs and favors disassembly, this would tend to increase MT assembly relative to other conditions, as we found. Additionally, if MTs are not needed as compressive supports, neurites could grow out in their absence, as we also observed.
几个研究小组已经表明,在没有神经生长因子的情况下,PC12细胞会在细胞外基质(ECM)上延伸含微管的神经突,且没有延迟期。这与神经生长因子(NGF)诱导的神经突生长形成对比,后者会有几天的延迟期。在这个延迟期内,促进微管组装的微管相关蛋白(MAPs)的合成或激活增加,这显然是神经突延伸所必需的。我们研究了在有或没有神经突生长抑制剂的情况下,在ECM上生长的PC12神经突的生长情况和微管(MT)含量。在ECM上,无论是否预先暴露于NGF的细胞的神经突都含有正常密度的微管,但在其末端经常含有不寻常的微管环,这可能表明微管组装增加。在ECM上,在10 microM LiCl存在下,PC12细胞的神经突延伸频率明显高于在聚赖氨酸上。在其他底物上,LiCl显然通过抑制特定MAPs的磷酸化来抑制神经突生长(Burstein, D. E., P. J. Seeley, and L. A. Greene. 1985. J. Cell Biol. 101:862 - 870)。尽管在检查的60条Li(+)神经突中,35 - 45%被发现含有正常排列的微管,但25 - 30%被发现微管密度约为正常的15%。其余30%的这些神经突几乎没有微管,只含有偶尔的、不明确的短管状结构。我们还发现,在微管解聚药物诺考达唑存在的情况下,神经突会在ECM上延伸。在0.1微克/毫升诺考达唑时,ECM上的细胞产生的神经突含有正常密度的微管。这与在聚赖氨酸上生长的细胞中该剂量导致的神经突生长缺乏和现有神经突回缩形成对比。在0.2微克/毫升诺考达唑时,神经突再次大量长出,超微结构检查的五条神经突中有四条被发现完全没有微管。我们通过假设在ECM上生长缓解了微管作为神经突张力的抗压支撑的需求来解释这些结果(Dennerll, T. J., H. C. Joshi, U. L. Steel, R. E. Buxbaum, and S. R. Heidemann. 1988. J. Cell Biol. 107:665)。因为压缩会使微管不稳定并有利于解聚,这将倾向于相对于其他条件增加微管组装,正如我们所发现的。此外,如果微管不需要作为抗压支撑,神经突可以在没有微管的情况下长出,这也是我们所观察到的。